3-Bromo-6-methyl-5-nitropyridin-2-amine, 95.0%, 250mg

1-Boc-6-Methyl-1,4-diazepane, 95.0%, 1g

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-{[(propan-2-yl)[(1r,3s)-3-[2-(6-tert-butyl-1H-1,3-benzodiazol-2-yl)ethyl]cyclobutyl]amino]methyl}oxolane-3,4-diol, 99.99%, 100mg

tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate, 97%, 100mg

(1R,2R)-2-(DIPHENYLPHOSPHINO)CYCLOHEXANAMINE, 95%, 250mg

2-Chloromethyl-5-(4-methylphenyl)-1,3,4-oxadiazole, 1g

Cobalt(II) bromide, 97%, 500g

4-CHLORO-N,6-DIMETHYL-1,3,5-TRIAZIN-2-AMINE, 95.0%, 500mg

2-Methyl-5-nitro-3-(trifluoromethyl)pyridine, 95%, 1g

(R)-(4-CHLOROPHENYL)(PHENYL)METHANAMINE HCL, 97.0%, 100mg

Chloressigsäureethylester, >=98 %, zur Synthese, 250 ml, Glasverpackung

4-(3,4-dimethylphenyl)-6-(3,4,5-trimethoxyphenyl)pyrimidin-2-amine, 95.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)non-8-enoic acid, 95.0%, 10g